Doxiproct, pommade rectale

7680389320123 CH-38932 pommade rectale

Associated product:

DOXIPROCT ong tb 30 g
Doxiproct, pommade rectale
Doxiproct, pommade rectale
Doxiproct, pommade rectale
1 / 3
google

Article details

Package size
30
Selling units
30
Measure
g
Galenic form
pommade rectale
Galenic group
Unknown

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
02/06/2025
Patient information leaflet
Français
02/06/2025
Patient information leaflet
Italien
02/06/2025
Summary of Product Characteristics
Allemand
02/06/2025
Summary of Product Characteristics
Français
02/06/2025
Summary of Product Characteristics
Italien
02/06/2025

Detailed composition

Substance Quantity Type Category
(N/A)
40.0 MG Substance Wirkstoff (Principe actif)
(N/A)
20.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance ANTOX
(N/A)
0.15 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
60.0 MG Substance HBESI
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
310.0 MG Substance HBESI

Authorization holder

OM Pharma SA

1217 Meyrin

Authorization information

Swissmedic authorization number
38932
Drug name
Doxiproct, pommade rectale
Galenic form
REKS
ATC Code
C05AD01
Authorization status
Z
Dispensing category
D
First authorization
02/04/1975
Authorization expiration date
31/12/9999
IT Number
02.09.1.
Domain
Human medicine

Package details

Description (FR)
DOXIPROCT ong tb 30 g
Description (DE)
DOXIPROCT Salbe Tb 30 g
Market launch
02/04/1975
Narcotic (BTM)
No